Lyell Immunopharma, Inc.
For the period ended Nov 4, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 4, 2026 · Filed Nov 4, 2026
Use the contents to explore the available documents and sections.
LYEL$14.86-0.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Balance Sheet Data:
Balance Sheet Data:
| As of September 30, | As of December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Cash, cash equivalents and marketable securities | $193,988 | $247,220 |
| Property and equipment, net | $28,531 | $34,771 |
| Total assets | $273,854 | $340,052 |
| Total stockholders’ equity | $192,721 | $248,202 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.